Baird raised the firm’s price target on Intuitive Surgical (ISRG) to $707 from $690 and keeps an Outperform rating on the shares. The firm said they posted stellar Q4 results as their best in class growth should continue despits 2025 P&L headwinds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $670 from $538 at Piper Sandler
- Intuitive Surgical price target raised to $675 from $575 at JPMorgan
- Intuitive Surgical price target raised to $711 from $640 at Citi
- ISRG Earnings: Intuitive Surgical Stock Drops Despite Q4 Beat
- Intuitive Surgical Reports Strong Q4 2024 Performance